A live-virus "suicide" vaccine for human immunodeficiency virus

Cleveland Clinic Journal of Medicine

Volumn 64, Issue 5, 1997, Pages 269-274

  Kestler, Harry W ^a   Chakrabarti, Bimal K ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Molecular Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; VIRUS RNA; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; REVIEW; SUICIDE GENE;

EID: 0030918311     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.64.5.269     Document Type: Review

References (32)

1. Jenner E. An inquiry into the causes and effects of the variolae vaccina, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of cow-pox. 1798. Reprinted by Cassell and Co. LTD, 1896. Available in pamphlet vol. 4232, Army Medical Library, Washington, DC.
2. Sabin AB. Present status of attenuated live-virus poliomyelitis vaccine. JAMA 1956; 162:1589-1596.
3. Burns DP, Desrosiers, RC. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. J Virol 1991; 65:1843-1854.
4. Putkonen P, Nilsson C, Hild K, et al. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. J Med Primatol 1993; 22(2-3):100-103.
5. Hirsch VM, Goldstein S, Hynes NA, et al. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J Infect Dis 1994; 170(1):51-59.
6. Graham BS, Wright PF. Candidate AIDS vaccines. N Engl J Med 1995; 333(20):1331-1339.
7. Kestler HW, Li Y, Naidu YM, et al. Comparison of simian immunodeficiency virus isolates. Nature 1988; 331:619-621.
8. Kestler H, Kodama T, Ringler D, et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990; 248:1109-1112.
9. Kestler HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 1991; 191:651-662.
10. Daniel MD, Kirschhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef. Science 1992; 258:1938-1941.
11. Kirschhoff F, Kestler HW, Desrosiers RC. Upstream sequences in SIV are selectively deleted in vivo in the absence of nef function. J Virol 1994; 68:2031-2037.
12. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 1995; 267:1820-1825.
13. Wyand MS, Manson KH, Lackner AA, Desrosiers RC. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Nature Medicine 19973; 3:32-36.
14. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995; 270:988-991.
15. Kirschhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995; 332(4):228-232.
16. Temin HM. A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1993; 90:4419-4420.
17. Desrosiers RC. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res Hum Retroviruses 1992; 8:1457.
18. Kestler HW, Jeang K-T. The safety of a live attenuated vaccine for AIDS. Science 1995; 270:1219.
19. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 1992; 358(6382):162-164.
20. Oxford JS. Inhibition of herpes virus by a new compound - acyclic guanosine. J Antimicrob Chemother 1979; 5(4):333-334.
21. Teare EL, Clements MR. Acyclovir for suspected systemic herpes infections. Lancet 1980; 1(8158):42.
22. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256(5063):1550-1552.
23. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265(5173):781-784.
24. Chakrabarti BK, Maitra RK, Ma X-Z, Kestler HW. A candidate live inactivatable attenuated vaccine for AIDS. Proc Natl Acad Sci U S A 1996; 93:9810-9815.
25. Smith SM, Markham RB, Jeang K-T. Conditional reduction of HIV-1 replication by a gain of HSV-1 thymidine kinase. Proc Natl Acad Sci U S A 1996; 93:7955-7960.
26. Baldanti F, Silini E, Sarasini A, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol 1995; 69(2):796-800.
27. Ji JP, Loeb LA. Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry 1992; 31:954-958.
28. Tenser RB. Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency. Intervirology 1991; 32:76-92.
29. Meyerhans A, Vartanian JP, Hultgren C, et al. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol 1994; 68:535-540.
30. Jacobsson B, Britton S, He Q, Karlsson A, Eriksson S. Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res Hum Retroviruses 1995; 11:805-811.
31. Pantaleo JG, Graziosi C, Butini L, et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A 1991; 88:9838-9842.
32. Salkowitz JR, Chakrabarti BK, Yen-Lieberman B, Starkey C, Bendele T, Kestler HW. The nef gene of SIVmac239 is necessary for efficient growth in H9 cells. J Biomed Sci 1996; 3:422-434.